Meco D - Search Results

1

The combination of yondelis and cisplatin is synergistic against human tumor xenografts.

D'Incalci M, Colombo T, Ubezio P, Nicoletti I, Giavazzi R, Erba E, Ferrarese L, Meco D, Riccardi R, Sessa C, Cavallini E, Jimeno J, Faircloth GT. D'Incalci M, et al. Among authors: meco d. Eur J Cancer. 2003 Sep;39(13):1920-6. doi: 10.1016/s0959-8049(03)00490-8. Eur J Cancer. 2003. PMID: 12932672

2

Antitumour activity of oxaliplatin in neuroblastoma cell lines.

Riccardi A, Ferlini C, Meco D, Mastrangelo R, Scambia G, Riccardi R. Riccardi A, et al. Among authors: meco d. Eur J Cancer. 1999 Jan;35(1):86-90. doi: 10.1016/s0959-8049(98)00342-6. Eur J Cancer. 1999. PMID: 10211093

3

Influence of cisplatin and doxorubicin on 125I-meta-iodobenzylguanidine uptake in human neuroblastoma cell lines.

Meco D, Lasorella A, Riccardi A, Servidei T, Mastrangelo R, Riccardi R. Meco D, et al. Eur J Cancer. 1999 Aug;35(8):1227-34. doi: 10.1016/s0959-8049(99)00078-7. Eur J Cancer. 1999. PMID: 10615234

4

The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin.

Servidei T, Ferlini C, Riccardi A, Meco D, Scambia G, Segni G, Manzotti C, Riccardi R. Servidei T, et al. Among authors: meco d. Eur J Cancer. 2001 May;37(7):930-8. doi: 10.1016/s0959-8049(01)00061-2. Eur J Cancer. 2001. PMID: 11313183

5

In vitro and in vivo antitumor activity of the novel trinuclear platinum complex BBR 3464 in neuroblastoma.

Riccardi A, Meco D, Ferlini C, Servidei T, Carelli G, Segni G, Manzotti C, Riccardi R. Riccardi A, et al. Among authors: meco d. Cancer Chemother Pharmacol. 2001 Jun;47(6):498-504. doi: 10.1007/s002800000264. Cancer Chemother Pharmacol. 2001. PMID: 11459202

6

Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies.

Meco D, Colombo T, Ubezio P, Zucchetti M, Zaffaroni M, Riccardi A, Faircloth G, Jose J, D'Incalci M, Riccardi R. Meco D, et al. Among authors: d incalci m. Cancer Chemother Pharmacol. 2003 Aug;52(2):131-8. doi: 10.1007/s00280-003-0636-6. Epub 2003 May 29. Cancer Chemother Pharmacol. 2003. PMID: 12783202

7

Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the rat.

Donald S, Verschoyle RD, Greaves P, Gant TW, Colombo T, Zaffaroni M, Frapolli R, Zucchetti M, D'Incalci M, Meco D, Riccardi R, Lopez-Lazaro L, Jimeno J, Gescher AJ. Donald S, et al. Among authors: d incalci m, meco d. Cancer Res. 2003 Sep 15;63(18):5902-8. Cancer Res. 2003. PMID: 14522916

8

Antitumor activity of imatinib mesylate in neuroblastoma xenografts.

Meco D, Riccardi A, Servidei T, Brueggen J, Gessi M, Riccardi R, Dominici C. Meco D, et al. Cancer Lett. 2005 Oct 18;228(1-2):211-9. doi: 10.1016/j.canlet.2005.02.054. Cancer Lett. 2005. PMID: 15950376 Review.

9

Combination of trabectedin and irinotecan is highly effective in a human rhabdomyosarcoma xenograft.

Riccardi A, Meco D, Ubezio P, Mazzarella G, Marabese M, Faircloth GT, Jimeno J, D'Incalci M, Riccardi R. Riccardi A, et al. Among authors: meco d, d incalci m. Anticancer Drugs. 2005 Sep;16(8):811-5. doi: 10.1097/01.cad.0000172837.67766.6a. Anticancer Drugs. 2005. PMID: 16096428

10

The novel lipophilic camptothecin analogue gimatecan is very active in vitro in human neuroblastoma: a comparative study with SN38 and topotecan.

Di Francesco AM, Riccardi A, Barone G, Rutella S, Meco D, Frapolli R, Zucchetti M, D'Incalci M, Pisano C, Carminati P, Riccardi R. Di Francesco AM, et al. Among authors: meco d, d incalci m. Biochem Pharmacol. 2005 Oct 15;70(8):1125-36. doi: 10.1016/j.bcp.2005.07.009. Biochem Pharmacol. 2005. PMID: 16139802

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters